Benjamin F. Edwards & Company’s Rockwell Medical RMTI Stock Holding History

Benjamin F. Edwards & Company’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-64	Closed	-$1K	–	1832
2023 Q1	$1K	Sell	64 -9	-12%	-$155	﹤0.01%	1744
2022 Q4	$1K	Hold	73	–	–	﹤0.01%	1805
2022 Q3	$1K	Hold	73	–	–	﹤0.01%	1783
2022 Q2	$1K	Hold	73	–	–	﹤0.01%	1772
2022 Q1	$4K	Sell	73 -9	-11%	-$381	﹤0.01%	1577
2021 Q4	$4K	Hold	82	–	–	﹤0.01%	1565
2021 Q3	$5K	Hold	82	–	–	﹤0.01%	1537
2021 Q2	$8K	Hold	82	–	–	﹤0.01%	1430
2021 Q1	$10K	Hold	82	–	–	﹤0.01%	1365
2020 Q4	$9K	Hold	82	–	–	﹤0.01%	1310
2020 Q3	$10K	Hold	82	–	–	﹤0.01%	1280
2020 Q2	$18K	Hold	82	–	–	﹤0.01%	1157
2020 Q1	$18K	Hold	82	–	–	﹤0.01%	1109
2019 Q4	$22K	Hold	82	–	–	﹤0.01%	1211
2019 Q3	$25K	Hold	82	–	–	﹤0.01%	1128
2019 Q2	$27K	Hold	82	–	–	﹤0.01%	1104
2019 Q1	$51K	Hold	82	–	–	﹤0.01%	869
2018 Q4	$20K	Buy	+82	New	+$32.6K	﹤0.01%	1090

Other funds holding RMTI

Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Benjamin F. Edwards & Company's RMTI Position: Q2 2023 in Review

Benjamin F. Edwards & Company sold out of Rockwell Medical (RMTI) in Q2 2023, closing a stake of 64 shares — an estimated $1K sold.

Benjamin F. Edwards & Company first reported a position in RMTI in Q4 2018 and held it in 18 quarters. The position peaked at $51K in Q1 2019. 40 funds tracked by Wall St. Rank hold RMTI as of Q2 2023.

Benjamin F. Edwards & Company reported no remaining Rockwell Medical position as of Q2 2023 after selling out during the quarter.
Benjamin F. Edwards & Company sold 64 Rockwell Medical shares in Q2 2023, an estimated $1K.
Benjamin F. Edwards & Company first reported a position in Rockwell Medical in Q4 2018 and held it in 18 quarters.
Benjamin F. Edwards & Company's Rockwell Medical position peaked at $51K in Q1 2019.
40 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2023.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2023, filed 15 Aug 2023.